Dentsply Sirona (NASDAQ: XRAY) enters new U.S. Patterson distribution pacts

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. reported that it has entered into new non-exclusive distribution agreements with Patterson for the distribution of its dental equipment in the United States. The company disclosed this development through a current report and attached a press release as Exhibit 99.1 describing the arrangements. The disclosure is made under Regulation FD and is treated as information that is furnished rather than filed under the securities laws, which limits how it is incorporated into other company reports.

0000818479false00008184792024-01-142026-01-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

January 14, 2026

Date of Report (Date of earliest event reported)

DENTSPLY SIRONA Inc.

(Exact name of registrant as specified in its charter)

Delaware

0-16211

39-1434669

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

13320 Ballantyne Corporate Place,

Charlotte

North Carolina

28277-3607

(Address of principal executive offices)

(Zip Code)

(844) 848-0137

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01 per share			XRAY			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

o

Item 7.01 Regulation FD Disclosure

The Company’s press release announcing it has successfully entered into new non-exclusive distribution agreements with Patterson for the distribution of dental equipment in the United States is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit No.						Description
99.1						DENTSPLY SIRONA Inc. Press Release Issued January 14, 2026
104						Cover Page Interactive Data File (embedded within the Inline XBRL Document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                         DENTSPLY SIRONA Inc.

By:						/s/ Daniel T. Scavilla
Name:						Daniel T. Scavilla
Title:						President and Chief Executive Officer

Date: January 14, 2026

FAQ

What did DENTSPLY SIRONA (XRAY) disclose in this 8-K filing?

DENTSPLY SIRONA disclosed that it has entered into new non-exclusive distribution agreements with Patterson covering the distribution of its dental equipment in the United States, described further in a related press release.

Who is DENTSPLY SIRONA’s new distribution partner mentioned in the filing?

The filing states that DENTSPLY SIRONA has new non-exclusive distribution agreements with Patterson for dental equipment in the United States.

How was the DENTSPLY SIRONA and Patterson distribution update communicated?

The company communicated the update through a Regulation FD disclosure, attaching a press release as Exhibit 99.1 to its current report.

Is the information about the Patterson agreements considered filed with the SEC?

No. The company states that the information provided under Item 7.01, including Exhibit 99.1, is furnished and not deemed filed for purposes of Section 18 of the Exchange Act.

What exhibit is associated with the DENTSPLY SIRONA (XRAY) distribution announcement?

The distribution announcement is contained in a press release listed as Exhibit 99.1, identified as a DENTSPLY SIRONA Inc. press release dated January 14, 2026.

What type of products are covered by the new Patterson agreements with DENTSPLY SIRONA?

The filing specifies that the new non-exclusive agreements with Patterson relate to the distribution of dental equipment in the United States.